- Home
- XOMA vs PSNYW Comparison
XOMA vs PSNYW Comparison
Compare XOMA & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- PSNYW
- Stock Information
- Founded
- XOMA 1981
- PSNYW 2017
- Country
- XOMA United States
- PSNYW Sweden
- Employees
- XOMA N/A
- PSNYW 2547
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- PSNYW Auto Manufacturing
- Sector
- XOMA Health Care
- PSNYW Consumer Discretionary
- Exchange
- XOMA Nasdaq
- PSNYW Nasdaq
- Market Cap
- XOMA 330.2M
- PSNYW 348.4M
- IPO Year
- XOMA N/A
- PSNYW N/A
- Fundamental
- Price
- XOMA $30.85
- PSNYW $0.16
- Analyst Decision
- XOMA Strong Buy
- PSNYW
- Analyst Count
- XOMA 2
- PSNYW 0
- Target Price
- XOMA $69.50
- PSNYW N/A
- AVG Volume (30 Days)
- XOMA 30.3K
- PSNYW 43.4K
- Earning Date
- XOMA 08-13-2025
- PSNYW 03-06-2025
- Dividend Yield
- XOMA N/A
- PSNYW N/A
- EPS Growth
- XOMA N/A
- PSNYW N/A
- EPS
- XOMA N/A
- PSNYW N/A
- Revenue
- XOMA $44,952,000.00
- PSNYW $2,034,261,000.00
- Revenue This Year
- XOMA $70.91
- PSNYW N/A
- Revenue Next Year
- XOMA $14.00
- PSNYW $79.49
- P/E Ratio
- XOMA N/A
- PSNYW N/A
- Revenue Growth
- XOMA 194.98
- PSNYW N/A
- 52 Week Low
- XOMA $18.35
- PSNYW $0.09
- 52 Week High
- XOMA $35.00
- PSNYW $0.61
- Technical
- Relative Strength Index (RSI)
- XOMA 67.84
- PSNYW 51.35
- Support Level
- XOMA $25.15
- PSNYW $0.15
- Resistance Level
- XOMA $33.15
- PSNYW $0.18
- Average True Range (ATR)
- XOMA 1.69
- PSNYW 0.01
- MACD
- XOMA 0.59
- PSNYW 0.00
- Stochastic Oscillator
- XOMA 79.66
- PSNYW 36.30
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.